Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (371-380 of 416) with videos related to

Pageof 42
Sort By:
Gastroenterology|April 19, 2006
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 4, 2013
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysisShingo Yamada, Atsushi Kawaguchi, Takumi Kawaguchi, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulationMotokazu Mukaide, Yasuhito Tanaka, Tadasu Shin-I, et al.
Molecular Medicine Reports|April 8, 2011
Redox state of albumin is not associated with colloid osmotic pressureMasahiro Sakata, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 3, 2013
Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infectionNoriaki Kawano, Satoru Hasuike, Hisayoshi Iwakiri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 6, 2013
Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis CTakashi Yamaguchi, Koichi Matsuzaki, Ryosuke Inokuchi, et al.
The American Journal of Pathology|October 29, 2004
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3Takumi Kawaguchi, Takafumi Yoshida, Masaru Harada, et al.
International Journal of Hematology|May 10, 2008
Periostin and bone marrow fibrosisEijiro Oku, Taisuke Kanaji, Yuka Takata, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 1, 2009
Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter studyYumiko Nagao, Hisako Matsuoka, Masataka Seike, et al.
Hepatology International|August 12, 2009
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in JapanYoshiaki Iwasaki, Yasushi Shiratori, Shuhei Hige, et al.
Pageof 42

Showing results (371-380 of 416) with videos related to

Sort By:
Pageof 42
Gastroenterology|April 19, 2006
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 4, 2013
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysisShingo Yamada, Atsushi Kawaguchi, Takumi Kawaguchi, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulationMotokazu Mukaide, Yasuhito Tanaka, Tadasu Shin-I, et al.
Molecular Medicine Reports|April 8, 2011
Redox state of albumin is not associated with colloid osmotic pressureMasahiro Sakata, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 3, 2013
Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infectionNoriaki Kawano, Satoru Hasuike, Hisayoshi Iwakiri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 6, 2013
Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis CTakashi Yamaguchi, Koichi Matsuzaki, Ryosuke Inokuchi, et al.
The American Journal of Pathology|October 29, 2004
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3Takumi Kawaguchi, Takafumi Yoshida, Masaru Harada, et al.
International Journal of Hematology|May 10, 2008
Periostin and bone marrow fibrosisEijiro Oku, Taisuke Kanaji, Yuka Takata, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 1, 2009
Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter studyYumiko Nagao, Hisako Matsuoka, Masataka Seike, et al.
Hepatology International|August 12, 2009
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in JapanYoshiaki Iwasaki, Yasushi Shiratori, Shuhei Hige, et al.
Pageof 42